MEDISTIM ASA (MEDI.OL) Stock Overview
Europe - OSL:MEDI - NO0010159684 - Common Stock
MEDI.OL Key Statistics, Chart & Performance
The current stock price of MEDI.OL is 278 NOK. In the past month the price increased by 23.56%. In the past year, price increased by 75.39%.
MEDI.OL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABL.DE | ABBOTT LABORATORIES | 24.97 | 186.44B | ||
| IUI1.DE | INTUITIVE SURGICAL INC | 63.2 | 167.66B | ||
| 1ISRG.MI | INTUITIVE SURGICAL INC | 54.14 | 143.61B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 34.25 | 128.91B | ||
| 1BSX.MI | BOSTON SCIENTIFIC CORP | 35.31 | 127.13B | ||
| 2M6.DE | MEDTRONIC PLC | 16.95 | 103.27B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 20.66 | 55.45B | ||
| BOX.DE | BECTON DICKINSON AND CO | 12.94 | 45.52B | ||
| EWL.DE | EDWARDS LIFESCIENCES CORP | 31.72 | 41.16B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 17.04 | 23.63B | ||
| 1DXCM.MI | DEXCOM INC | 40.45 | 23.16B | ||
| DC4.DE | DEXCOM INC | 40.26 | 23.05B |
Related stock screener links
About MEDI.OL
Company Profile
Medistim ASA engages in the development, manufacture, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo and currently employs 154 full-time employees. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the outcome of cardiac and vascular surgery. The firm provides Transit Time Flow Measurement (TTFM) and ultrasound imaging to the global market to enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery. Medistim’s activities are divided into two business units: Own Products Category and Third-Party Products Category. Furthermore, the Company has several subsidiaries, including Medistim USA Inc, Medistim Norge AS and Medistim Japan KK.
Company Info
MEDISTIM ASA
Okernveien 94
Oslo OSLO NO
Employees: 154
Phone: 4723059660
MEDISTIM ASA / MEDI.OL FAQ
What does MEDISTIM ASA do?
Medistim ASA engages in the development, manufacture, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo and currently employs 154 full-time employees. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the outcome of cardiac and vascular surgery. The firm provides Transit Time Flow Measurement (TTFM) and ultrasound imaging to the global market to enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery. Medistim’s activities are divided into two business units: Own Products Category and Third-Party Products Category. Furthermore, the Company has several subsidiaries, including Medistim USA Inc, Medistim Norge AS and Medistim Japan KK.
What is the stock price of MEDISTIM ASA today?
The current stock price of MEDI.OL is 278 NOK. The price decreased by -2.11% in the last trading session.
What is the dividend status of MEDISTIM ASA?
MEDISTIM ASA (MEDI.OL) has a dividend yield of 2.38%. The yearly dividend amount is currently 4.5.
What is the ChartMill technical and fundamental rating of MEDI stock?
MEDI.OL has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
What is the GICS sector and industry of MEDI stock?
MEDISTIM ASA (MEDI.OL) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Is MEDISTIM ASA (MEDI.OL) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on MEDI.OL.
What is MEDISTIM ASA worth?
MEDISTIM ASA (MEDI.OL) has a market capitalization of 5.10B NOK. This makes MEDI.OL a Mid Cap stock.
MEDI.OL Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to MEDI.OL. When comparing the yearly performance of all stocks, MEDI.OL is one of the better performing stocks in the market, outperforming 91.98% of all stocks.
MEDI.OL Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to MEDI.OL. Both the health and profitability get an excellent rating, making MEDI.OL a very profitable company, without any liquidiy or solvency issues.
MEDI.OL Financial Highlights
Over the last trailing twelve months MEDI.OL reported a non-GAAP Earnings per Share(EPS) of 7.17. The EPS increased by 25.76% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 20.67% | ||
| ROA | 24.51% | ||
| ROE | 34.17% | ||
| Debt/Equity | 0.06 |
MEDI.OL Forecast & Estimates
8 analysts have analysed MEDI.OL and the average price target is 260.1 NOK. This implies a price decrease of -6.44% is expected in the next year compared to the current price of 278.
For the next year, analysts expect an EPS growth of 16.97% and a revenue growth 17.55% for MEDI.OL